These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1612574)

  • 1. Radiation therapy for nasopharyngeal carcinoma: histologic appearances and patterns of tumor regression.
    Nicholls JM; Sham J; Chan CW; Choy D
    Hum Pathol; 1992 Jul; 23(7):742-7. PubMed ID: 1612574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal carcinoma. Pattern of tumor regression after radiotherapy.
    Sham JS; Wei WI; Kwan WH; Chan CW; Kwong WK; Choy D
    Cancer; 1990 Jan; 65(2):216-20. PubMed ID: 2295044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of endoscopic and histologic findings before and after treatment for nasopharyngeal carcinoma.
    Kwong DL; Nicholls J; Wei WI; Chua DT; Sham JS; Yuen PW; Cheng AC; Yau CC; Kwong PW; Choy DT
    Head Neck; 2001 Jan; 23(1):34-41. PubMed ID: 11190856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma.
    Kwong DL; Wei WI; Cheng AC; Choy DT; Lo AT; Wu PM; Sham JS
    Cancer; 2001 Mar; 91(6):1105-13. PubMed ID: 11267955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of local failures after management of nasopharyngeal carcinoma: a prospective, controlled trial.
    Ragab SM; Erfan FA; Khalifa MA; Korayem EM; Tawfik HA
    J Laryngol Otol; 2008 Nov; 122(11):1230-4. PubMed ID: 18371235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of biopsy on the prognosis of nasopharyngeal carcinoma--a critical study of biopsy from the nasopharynx and cervical lymph node of 649 patients.
    Cai WM; Zhang HX; Hu YH; Gu XZ
    Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1439-44. PubMed ID: 6629887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma.
    Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH
    Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma.
    Kwong DL; Nicholls J; Wei WI; Chua DT; Sham JS; Yuen PW; Cheng AC; Wan KY; Kwong PW; Choy DT
    Cancer; 1999 Apr; 85(7):1446-53. PubMed ID: 10193933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of clinic biopsy specimens in classifying histopathologic characteristics of recurrent nasopharyngeal carcinoma.
    Brown JJ; Berry GJ; Moretto J; Keating WF; Fee WE
    Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):950-5. PubMed ID: 9305245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early stage nasopharyngeal carcinoma: radiotherapy dose and time factors in tumor control.
    Chang JT; See LC; Liao CT; Chen LH; Leung WM; Chen SW; Chen WC
    Jpn J Clin Oncol; 1998 Mar; 28(3):207-13. PubMed ID: 9614445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of computed tomography imaging in predicting response of nasopharyngeal carcinoma to definitive radiation therapy.
    Ma X; Lu JJ; Loh KS; Shakespeare TP; Thiagarajan A; Goh BC; Tan KS
    Laryngoscope; 2006 Dec; 116(12):2162-5. PubMed ID: 17146390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.
    He Y; Zhou Q; Shen L; Zhao Y; Lei M; Wei R; Shen L; Cao S
    Radiat Oncol; 2015 Apr; 10():89. PubMed ID: 25881159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short-and long-term therapeutic effects of brachytherapy on intracavitary residual tumor in 563 nasopharyngeal carcinoma (NPC) patients].
    Cao X; Chen K; He Z
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):146-7. PubMed ID: 10920969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-radiation Plasma Epstein-Barr Virus DNA and Local Clinical Remission After Radical Intensity-modulated Radiation Therapy for Nasopharyngeal Carcinoma.
    Lee VH; Kwong DL; Leung TW; Choi CW; Lam KO; Sze CK; Ho P; Chan WL; Wong LS; Leung D
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):42-9. PubMed ID: 26482452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Split-palate approach for gold grain implantation in nasopharyngeal carcinoma.
    Wei WI; Sham JS; Choy D; Ho CM; Lam KH
    Arch Otolaryngol Head Neck Surg; 1990 May; 116(5):578-82. PubMed ID: 2328116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control.
    Sanguineti G; Geara FB; Garden AS; Tucker SL; Ang KK; Morrison WH; Peters LJ
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):985-96. PubMed ID: 9169804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
    Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
    Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.